Br J Ophthalmol 1998;82:181-185 ( February )
Platelet derived growth factor and fibroblast growth factor basic
levels in the vitreous of patients with vitreoretinal disorders
L Cassidy,a b
P Barry,b
C Shaw,d
M J Duffy,e
S Kennedya c
a Research Department, The Royal Victoria Eye & Ear Hospital, Dublin, b Department of Ophthalmology, The Royal Victoria Eye & Ear
Hospital, Dublin, c National
Ophthalmic Pathology Laboratory, The Royal Victoria Eye & Ear Hospital,
Dublin, d University College Dublin,
Belfield, Dublin, e Department of Nuclear
Medicine, St Vincent's Hospital, Dublin
Correspondence to: Miss Lorraine Cassidy, Ophthalmology
Department, Clarendon Wing, Leeds General Infirmary, Belmont Grove,
Leeds LS2 9NS.
Accepted for publication 13
August 1997
AIM To determine the potential role of basic
fibroblast growth factor (bFGF) and platelet derived growth factor
(PDGF) in the pathogenesis of proliferative vitreoretinopathy (PVR).
METHODS An enzyme linked immunosorbent assay
technique was used to determine the quantities of bFGF and PDGF in 38 vitreous samples taken from patients undergoing trans pars plana
vitrectomy (PPV) for a variety of vitreoretinal disorders.
RESULTS bFGF levels ranged from undetectable to
318.7 pg/ml. The mean concentration was 27.57 pg/ml. PDGF levels ranged
from undetectable to 160 pg/ml, the mean concentration being 40.06 pg/ml. Eight of 13 patients with clinical evidence of retinal
detachment (RD) and PVR had significantly elevated bFGF concentrations,
whereas only one of 11 patients with RD and no PVR had detectable bFGF; seven of eight patients with RD and PVR had elevated PDGF
concentrations in the vitreous, whereas all 10 patients with RD and no
PVR had no detectable vitreous PDGF. Eight patients with vitreous
haemorrhage had raised PDGF concentrations, and the levels were
particularly high (>120 pg/ml) in those two patients with active
neovascularisation. Two out of nine patients with vitreous haemorrhage
had raised bFGF levels.
CONCLUSIONS bFGF and PDGF concentrations are
elevated in PVR even in the absence of vitreous haemorrhage, and not in
patients with RD uncomplicated by PVR. This observation suggests that
both cytokines may be involved in the pathogenesis of PVR.
Keywords:
basic fibroblast growth factor;
platelet derived
growth factor;
proliferative vitreoretinopathy
© 1998 by British Journal of Ophthalmology
Relevant Article
-
Growth factors in proliferative vitreoretinopathy
- DAVID G CHARTERIS
Br. J. Ophthalmol. 1998 82: 106.
[Extract]
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
H. Kaneko, K. M. Nishiguchi, M. Nakamura, S. Kachi, and H. Terasaki
Retardation of Photoreceptor Degeneration in the Detached Retina of rd1 Mouse
Invest. Ophthalmol. Vis. Sci.,
February 1, 2008;
49(2):
781 - 787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lei, P. Hovland, G. Velez, A. Haran, D. Gilbertson, T. Hirose, and A. Kazlauskas
A Potential Role for PDGF-C in Experimental and Clinical Proliferative Vitreoretinopathy
Invest. Ophthalmol. Vis. Sci.,
May 1, 2007;
48(5):
2335 - 2342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Saika, O. Yamanaka, I. Nishikawa-Ishida, A. Kitano, K. C. Flanders, Y. Okada, Y. Ohnishi, Y. Nakajima, and K. Ikeda
Effect of Smad7 Gene Overexpression on Transforming Growth Factor beta-Induced Retinal Pigment Fibrosis in a Proliferative Vitreoretinopathy Mouse Model
Arch Ophthalmol,
May 1, 2007;
125(5):
647 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mukherjee and C. Guidry
The Insulin-Like Growth Factor System Modulates Retinal Pigment Epithelial Cell Tractional Force Generation
Invest. Ophthalmol. Vis. Sci.,
April 1, 2007;
48(4):
1892 - 1899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Priglinger, C. S. Alge, T. C. Kreutzer, A. S. Neubauer, C. Haritoglou, A. Kampik, and U. Welge-Luessen
Keratinocyte Transglutaminase in Proliferative Vitreoretinopathy
Invest. Ophthalmol. Vis. Sci.,
November 1, 2006;
47(11):
4990 - 4997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Alge, S. G. Priglinger, D. Kook, H. Schmid, C. Haritoglou, U. Welge-Lussen, and A. Kampik
Galectin-1 Influences Migration of Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
January 1, 2006;
47(1):
415 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hirayama, Y. Hata, Y. Noda, M. Miura, I. Yamanaka, H. Shimokawa, and T. Ishibashi
The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes
Invest. Ophthalmol. Vis. Sci.,
November 1, 2004;
45(11):
3896 - 3903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R H Y Asaria, C H Kon, C Bunce, C S Sethi, G A Limb, P T Khaw, G W Aylward, and D G Charteris
Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid
Br. J. Ophthalmol.,
November 1, 2004;
88(11):
1439 - 1442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hollborn, G. Birkenmeier, A. Saalbach, I. Iandiev, A. Reichenbach, P. Wiedemann, and L. Kohen
Expression of LRP1 in Retinal Pigment Epithelial Cells and Its Regulation by Growth Factors
Invest. Ophthalmol. Vis. Sci.,
June 1, 2004;
45(6):
2033 - 2038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tanaka, J. Utsumi, M. Matsui, T. Sudo, N. Nakamura, M. Mutoh, A. Kajita, S. Sone, K. Kigasawa, M. Shibuya, et al.
Purification, Molecular Cloning, and Expression of a Novel Growth-Promoting Factor for Retinal Pigment Epithelial Cells, REF-1/TFPI-2
Invest. Ophthalmol. Vis. Sci.,
January 1, 2004;
45(1):
245 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamane, A. Minamoto, H. Yamashita, H. Takamura, Y. Miyamoto-Myoken, K. Yoshizato, T. Nabetani, A. Tsugita, and H. K. Mishima
Proteome Analysis of Human Vitreous Proteins
Mol. Cell. Proteomics,
November 1, 2003;
2(11):
1177 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Troger, S Sellemond, G Kieselbach, M Kralinger, E Schmid, B Teuchner, Q A Nguyen, E Schretter-Irschick, and W Gottinger
Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells
Br. J. Ophthalmol.,
November 1, 2003;
87(11):
1403 - 1408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Nicoletti, I Venza, G Ceci, M Visalli, D Teti, and A Reibaldi
Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina
Br. J. Ophthalmol.,
August 1, 2003;
87(8):
1038 - 1042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Parapuram, R. Ganti, R. C. Hunt, and D. M. Hunt
Vitreous Induces Components of the Prostaglandin E2 Pathway in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
April 1, 2003;
44(4):
1767 - 1774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Milenkovic, M. Weick, P. Wiedemann, A. Reichenbach, and A. Bringmann
P2Y Receptor-Mediated Stimulation of Muller Glial Cell DNA Synthesis: Dependence on EGF and PDGF Receptor Transactivation
Invest. Ophthalmol. Vis. Sci.,
March 1, 2003;
44(3):
1211 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Van Aken, O. De Wever, L. Van Hoorde, E. Bruyneel, J.-J. De Laey, and M. M. Mareel
Invasion of Retinal Pigment Epithelial Cells: N-cadherin, Hepatocyte Growth Factor, and Focal Adhesion Kinase
Invest. Ophthalmol. Vis. Sci.,
February 1, 2003;
44(2):
463 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Lee, J. K. Park, Y.-T. Kim, B.-M. Kwon, S. G. Kang, Y. D. Yoo, Y. S. Yu, and H. Chung
Effect of 2'-Benzoyl-oxycinnamaldehyde on RPE Cells In Vitro and in an Experimental Proliferative Vitreoretinopathy Model
Invest. Ophthalmol. Vis. Sci.,
September 1, 2002;
43(9):
3117 - 3124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Hogg, I. Grierson, and P. Hiscott
Direct Comparison of the Migration of Three Cell Types Involved in Epiretinal Membrane Formation
Invest. Ophthalmol. Vis. Sci.,
August 1, 2002;
43(8):
2749 - 2757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikuno and A. Kazlauskas
An In Vivo Gene Therapy Approach for Experimental Proliferative Vitreoretinopathy Using the Truncated Platelet-Derived Growth Factor {alpha} Receptor
Invest. Ophthalmol. Vis. Sci.,
July 1, 2002;
43(7):
2406 - 2411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikuno, F.-L. Leong, and A. Kazlauskas
PI3K and PLC{gamma} Play a Central Role in Experimental PVR
Invest. Ophthalmol. Vis. Sci.,
February 1, 2002;
43(2):
483 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikuno and A. Kazlauskas
TGF{beta}1-Dependent Contraction of Fibroblasts Is Mediated by the PDGF{alpha} Receptor
Invest. Ophthalmol. Vis. Sci.,
January 1, 2002;
43(1):
41 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikuno, F.-L. Leong, and A. Kazlauskas
Attenuation of Experimental Proliferative Vitreoretinopathy by Inhibiting the Platelet-Derived Growth Factor Receptor
Invest. Ophthalmol. Vis. Sci.,
September 1, 2000;
41(10):
3107 - 3116.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Carrington, D. McLeod, and M. Boulton
IL-10 and Antibodies to TGF-{beta}2 and PDGF Inhibit RPE-Mediated Retinal Contraction
Invest. Ophthalmol. Vis. Sci.,
April 1, 2000;
41(5):
1210 - 1216.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G A. Limb and A. H Chignell
Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy
Br. J. Ophthalmol.,
August 1, 1999;
83(8):
953 - 956.
[Abstract]
[Full Text]
|
 |
|
|
|